These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4579659)

  • 1. The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis.
    Oosterhuis HJ; van der Slooten EP
    J Neurol Sci; 1973 Aug; 19(4):453-60. PubMed ID: 4579659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of myasthenia with adrencorticotrophins (ACTH and Synacthen). Apropos of 100 treatments in 25 patients].
    Goulon M; Nouailhat F; Barois A; Grosbuis S; Joron MH
    Rev Neurol (Paris); 1972 Oct; 127(4):457-70. PubMed ID: 4355521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of myasthenia with the aldosterone antagonist spironolactone].
    Lincke HO
    Munch Med Wochenschr; 1966 Feb; 108(5):270-4. PubMed ID: 6013740
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of severe myasthenia gravis with large doses of ACTH.
    von Reis G; Liljestrand A; Matell G
    Ann N Y Acad Sci; 1966 Jan; 135(1):409-16. PubMed ID: 4287550
    [No Abstract]   [Full Text] [Related]  

  • 5. Isotope studies of body composition in neuromuscular diseases.
    Delwaide PA; Delwaide PJ; Penders CA
    J Neurol Sci; 1972 Mar; 15(3):339-49. PubMed ID: 4622483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Triaminopteridine in the therapy of myasthenia gravis].
    Mansoldo G; Battocchia A; De Candia O
    Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
    [No Abstract]   [Full Text] [Related]  

  • 7. [The exchangeable potassium in hyper- thyroidism. Application to the study of amyotrophies and Basedowian myasthenia].
    Lefebvre J; Fossati P; Benoit G; Linquette M
    Ann Endocrinol (Paris); 1971; 32(1):83-94. PubMed ID: 4104092
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of exchangeable electrolyte measurement in the treatment of myasthenia gravis.
    Critchley M; Herman KJ; Harrison M; Shields RA; Liversedge LA
    J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):250-2. PubMed ID: 196049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
    Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
    Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE THERAPEUTIC ACTION OF SPIRONOLACTONE (ALDACTONE) IN MYASTHENIA GRAVIS: CLINICAL AND ELECTROMYOGRAPHIC FINDINGS IN 4 CASES].
    POLONI AE; SCARLATO G
    Sist Nerv; 1963; 15():401-11. PubMed ID: 14118442
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of exchangeable potassium in myasthenia and in certain other neurological diseases.
    Rowińska K; Kapuściński A
    Pol Med J; 1971; 10(3):750-6. PubMed ID: 4941886
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium metabolism in myasthenia gravis.
    Ozdemir C; Hatemi H; Ozturk EO
    Dis Nerv Syst; 1968 Dec; 29(12):834-6. PubMed ID: 5717297
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of aldactone and veroshpiron in complex therapy of patients with circulation disorders].
    Bezborod'ko BN; Shekhunova MI; Selivonenko VG
    Ter Arkh; 1973 Jan; 45(1):84-6. PubMed ID: 4770028
    [No Abstract]   [Full Text] [Related]  

  • 14. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.
    Seybold ME; Drachman DB
    N Engl J Med; 1974 Jan; 290(2):81-4. PubMed ID: 4808454
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 cases of myasthenia gravis with outstanding effects of massive potassium treatment--evaluation of potassium metabolism].
    Yoshikawa N; Noguchi S; Iguchi H; Morimune S; Nishitani H
    Nihon Rinsho; 1973 Feb; 31(2):401-3. PubMed ID: 4737130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the effect of spinonolactone on myasthenia gravis using a double blind test].
    Yamada S; Ishii Y; Noguchi H; Ohara H
    Naika; 1967 Apr; 19(4):739-41. PubMed ID: 6062155
    [No Abstract]   [Full Text] [Related]  

  • 17. Results with ACTH and spironolactone in severe cases of myasthenia gravis.
    von Reis G; Liljestrand A; Matell G
    Acta Neurol Scand Suppl; 1965; 13 Pt 2():463-71. PubMed ID: 4284453
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapeutic trials in myasthenia gravis.
    Ozdemir C; Hatemi H; Yardimci B
    Panminerva Med; 1974; 16(5-6):190-4. PubMed ID: 4424580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of myasthenia with spironolactone].
    Sepe O
    Minerva Med; 1969 Jul; 60(57):2870-7. PubMed ID: 5795380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis].
    Satoyoshi E; Nakazato H
    Naika; 1971 Jun; 27(6):1440-4. PubMed ID: 4326414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.